Sofosbuvir Withdrawn Phase 4 Trials for Hepatitis C Viral Infection / Chronic Renal Failure (CRF) Prevention

IndicationsStatusPurposePhase
WithdrawnPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03093740Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant